The SRY subsidiary of Jerusalem’s Hadassah Medical Center has developed Vizamyl, a radioactive agent that can diagnose Alzheimer’s disease. Used in a Positron Emission Tomography (PET) scan, it estimates amyloid neuritic plaque density in the brain – the main indication of Alzheimer’s.
New test for Alzheimer’s
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.